Skip to Main Content

WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington, is on leave from her role as CEO of the Biotechnology Innovation Organization, the group confirmed on Sunday.

“The BIO CEO is currently on leave. BIO does not speculate on rumors relative to employees or personnel,” BIO Chief Public Affairs and Marketing Officer Rich Masters said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment